Tianjin, China

Yuan Qin

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Accendatech, Tianjin International Joint Academy of Biotechnology & Medicine. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuan Qin. Retrieved from https://idiyas.com/inventor/yuan-qin-o76dete2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Yuan Qin

Introduction

Yuan Qin is a notable inventor based in Tianjin, China. He has made significant contributions to the field of biotechnology, particularly in the treatment of pulmonary fibrosis. His innovative approach has garnered attention in the medical community.

Latest Patents

Yuan Qin holds a patent titled "Method for treating pulmonary fibrosis comprising application of dimethylamino micheliolide." This invention provides a pharmaceutical application of dimethylamino micheliolide for preparing a product aimed at treating pulmonary fibrosis. His work in this area highlights the potential for new therapeutic options for patients suffering from this condition.

Career Highlights

Throughout his career, Yuan Qin has worked with prominent organizations such as the Tianjin International Joint Academy of Biotechnology and Medicine and Accendatech. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in biotechnology.

Collaborations

Yuan Qin has collaborated with talented individuals in his field, including coworkers Tao Sun and Yue Chen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and innovation.

Conclusion

Yuan Qin's contributions to the field of biotechnology, particularly through his patent for treating pulmonary fibrosis, demonstrate his commitment to advancing medical science. His work continues to inspire future innovations in the treatment of complex diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…